Get started
Author

Samuel Zylstra

Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder
2014 · Steven Siegel, Karen Noblett, et al. · Neurourology and Urodynamics · 218
Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation
2017 · Steven Siegel, Karen Noblett, et al. · The Journal of Urology · 192
Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation
2016 · Steven Siegel, Karen Noblett, et al. · Urology · 133
Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities
1988 · Myroslaw M. Hreshchyshyn, Amy Hopkins, et al. · American Journal of Obstetrics and Gynecology · 127
Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder
2014 · Karen Noblett, Steven Siegel, et al. · Neurourology and Urodynamics · 100
Single-incision apical and posterior mesh repair: 1-year prospective outcomes
2012 · James C. Lukban, Jan-Paul W. R. Roovers, et al. · International Urogynecology Journal · 39
Membrane-associated glycoprotein (gp 160) identified on human lung tumors by a monoclonal antibody.
1986 · S Zylstra, F A Chen, et al. · PubMed · 37
Defense of Breast Cancer Malpractice Claims
2001 · Samuel Zylstra, Carl J. D'Orsi, et al. · The Breast Journal · 18
Normal and Abnormal Features of the Lumbar Spine Observed in Dual Photon Absorptiometry Scans
1989 · AMY HOPKINS, SAMUEL ZYLSTRA, et al. · Clinical Nuclear Medicine · 16
Monoclonal Antibodies Specific for Two Different Histological Types of Human Lung Carcinoma
1984 · SHIGETOYO SAJI, SAMUEL ZYLSTRA, et al. · Hybridoma · 14
Statistical models of outcome in malpractice lawsuits involving death or neurologically impaired infants
1998 · Roy Bors-Koefoed, Samuel Zylstra, et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 12
Office Management of Benign Breast Disease
1999 · SAMUEL ZYLSTRA · Clinical Obstetrics & Gynecology · 7
A Prospective Multi-center Clinical Trial Evaluating the Apogee System for the Treatment of Posterior Vaginal Wall and Apical Prolapse
2008 · James Lukban, Ty B Erickson, et al. · The Journal of Urology · 4
Pd27-07 Evaluation of Quality of Life Improvements at 36 Months in Subjects With Overactive Bladder Treated With Sacral Neuromodulation Using the Interstim® System
2015 · Steven Siegel, Jason Bennett, et al. · The Journal of Urology · 2
A Cost Analysis of Ambulatory Antenatal Testing in a Tertiary Care Center
1993 · Roy Bors-Koefoed, Samuel Zylstra, et al. · The Journal of Maternal-Fetal & Neonatal Medicine · 1
Mp79-17 Level of Difficulty and Trauma Associated With Removal of the Tined Lead for Sacral Neuromodulation
2018 · Steven Siegel, Jeffrey Mangel, et al. · The Journal of Urology
PDF
Long-term neurostimulator programming in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients
2018 · Steven Siegel, Jeffrey Mangel, et al. · Neurourology and Urodynamics
Mp31-16 Concomitant Overactive Bladder Medication Usage After Sacral Neuromodulation Implant
2017 · Karen Noblett, Jeffrey Mangel, et al. · The Journal of Urology
Pd26-02 the Effect of Sacral Neuromodulation on Complete Continence at 5 Years for Subjects With Urinary Incontinence
2017 · Steven Siegel, Jeffrey Mangel, et al. · The Journal of Urology
Mp38-07 Effect of Baseline Characteristics and Test Stimulation Response on Sacral Neuromodulation Therapeutic Success at 12-months
2014 · Suzette E. Sutherland, Steven Siegel, et al. · The Journal of Urology
A Prospective, Multicenter Trial evaluating Efficacy, Safety and Quality of Life of Sacral Neuromodulation through 24 Months in Subjects with Symptoms of Overactive Bladder
2014 · Karen Noblett, Craig V. Comiter, et al. · Neurourology and Urodynamics
1034 Evaluation of Quality of Life Improvements at Twelve Months in Subjects With Overactive Bladder Treated With Sacral Neuromodulation Using the Interstim® System
2013 · Craig Comiter, Jason Bennett, et al. · The Journal of Urology
A Prospective, Randomized, Multi-centre Trial evaluating Efficacy, Quality of Life and Safety of Sacral Neuromodulation vs Standard Medical Treatment in Subjects with Symptoms of Overactive Bladder
2013 · Tomas L. Griebling, Samuel Zylstra, et al. · Neurourology and Urodynamics
Does pelvic mesh treated with phosphorylcholine improve outcomes? An early experience
2012 · Amit Chakrabarty, Kumaresan Ganabathi, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology
Statistical models of outcome in malpractice lawsuits involving death or neurologically impaired infants
1998 · Roy Bors‐Koefoed, Samuel Zylstra, et al. · The Journal of Maternal-Fetal Medicine
Works count: 26
Citation count: 920
H-index: 11
I10-index: 11
Year
Topic
Type